PHILIPS Image Guided Therapy

Specifications
- Global leader in image-guided therapy
- Integrates systems, software, and devices in one interventional platform
- Market-leading installed base
- Procedural growth rate of 5% CAGR from 2022-2025
- Addressable market of EUR 10 billion in 2023
Product Usage Instructions
System Integration
The product integrates systems, software, and devices to provide a comprehensive interventional platform. Ensure all components are properly connected and configured for optimal performance.
Procedure Workflow
Follow the clinical guidance provided by the software and AI for efficient procedure workflow. Utilize the integrated device console for seamless co-registration of imaging and physiology devices.
Device Readiness
Ensure that over 50% of labs are device-ready to drive customer intimacy and higher adoption of imaging and physiology devices.
Equip the labs with integrated device consoles for enhanced clinical support.
Clinical Innovation
- Stay updated on recent releases and advancements in interventional neurovascular, structural heart disease, and coronary segments.
- Utilize high-end invasive imaging tools and clinical evidence generation to drive innovation and standard setting in complex clinical areas.
FAQ
Q: How can I ensure optimal performance of the product?
A: Make sure all systems, software, and devices are properly integrated and configured. Stay updated on new releases and advancements to leverage the latest technology.
Q: What is the expected procedural growth rate?
A: The product has a projected 5% CAGR from 2022-2025, reflecting a steady increase in procedural volume.
Q: How can I drive customer intimacy with the product?
A: Ensure that your labs are device-ready and equipped with integrated device consoles. This will lead to higher adoption rates and better customer engagement.
Global leader uniquely integrating systems
software and devices in one interventional platform
Note: Last twelve months sales. Leadership positions in Philips’s addressable market
Serving interventional clinical
Serving interventional clinical segments with high growth rates
Attractive market growth supported by clear trends
Addressable market
Key market trends
- Growth of minimally invasive procedures and patient volume
- Innovation to treat new and/or more complex patient pools
- Clinical and economic evidence driving guidelines and reimbursement
- Expansion through increased adoption and procedure innovation
- Emergence of new growth geographies
- Improved procedural efficiency increases access to care
Shaping the market through unique
Shaping market through unique combination of systems and devices driving procedure workflow innovation, clinical adoption
Standard-setting innovation
Standard-setting innovation in complex clinical areas strengthens leadership positions and enables growth in adjacencies
Key takeaways
- Global leader, with the largest installed base
- High market growth driven by the move to minimally invasive, emerging therapies
- Sole player integrating systems, software, and devices offering end-to-end
- Leading procedural workflow innovation, with measurable clinical benefits in core and adjacencies
- Uniquely positioned interventional sales teams, driving deep customer intimacy

Documents / Resources
![]() | Image Guided Therapy |
References
- User Manualmanual.tools

